相似文献
1
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations.
Nat Rev Urol. 2024 Sep;21(9):513-514. doi: 10.1038/s41585-024-00880-0.
2
Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.
Semin Nephrol. 2025 Jul;45(4):151655. doi: 10.1016/j.semnephrol.2025.151655. Epub 2025 Jul 15.
3
Personalized Intervention in Monogenic Stone Formers.
J Urol. 2018 Mar;199(3):623-632. doi: 10.1016/j.juro.2017.09.143. Epub 2017 Oct 20.
4
Unraveling the role of gut microbiota on the formation of nephrolithiasis: insights from integrated analysis of GWAS, single-cell transcriptomics, bulk RNA sequencing and network Pharmacology.
Urolithiasis. 2025 Jul 15;53(1):138. doi: 10.1007/s00240-025-01809-x.
5
The Yield of Genetic Testing in Management of Nephrolithiasis.
Urology. 2024 Nov;193:27-34. doi: 10.1016/j.urology.2024.07.002. Epub 2024 Jul 9.
6
Oily fish intake reduces the risk of nephrolithiasis: A cross-sectional and Mendelian randomization study.
Clin Nephrol. 2025 Aug;104(2):134-143. doi: 10.5414/CN111667.
7
Macrophage Reprogramming: Emerging Molecular Therapeutic Strategies for Nephrolithiasis.
Biomolecules. 2025 Jul 28;15(8):1090. doi: 10.3390/biom15081090.
8
Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies.
Arthritis Res Ther. 2015 Apr 1;17(1):90. doi: 10.1186/s13075-015-0610-9.
9
Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or Nephrocalcinosis.
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):664-72. doi: 10.2215/CJN.07540715. Epub 2016 Jan 19.
10
Re: Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
J Urol. 2015 Jun;193(6):2008. doi: 10.1016/j.juro.2015.03.033. Epub 2015 Mar 17.
本文引用的文献
1
OXGR1 is a candidate disease gene for human calcium oxalate nephrolithiasis.
Genet Med. 2023 Mar;25(3):100351. doi: 10.1016/j.gim.2022.11.019. Epub 2022 Dec 6.
2
PHYOX2: a pivotal randomized study of nedosiran in primary hyperoxaluria type 1 or 2.
Kidney Int. 2023 Jan;103(1):207-217. doi: 10.1016/j.kint.2022.07.025. Epub 2022 Aug 22.
3
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712.
4
Genetics of kidney stone disease.
Nat Rev Urol. 2020 Jul;17(7):407-421. doi: 10.1038/s41585-020-0332-x. Epub 2020 Jun 12.
5
Genetic variants of calcium and vitamin D metabolism in kidney stone disease.
Nat Commun. 2019 Nov 15;10(1):5175. doi: 10.1038/s41467-019-13145-x.
6
Acidosis and Deafness in Patients with Recessive Mutations in FOXI1.
J Am Soc Nephrol. 2018 Mar;29(3):1041-1048. doi: 10.1681/ASN.2017080840. Epub 2017 Dec 14.
7
A Single Nucleotide Polymorphism (rs4236480) in TRPV5 Calcium Channel Gene Is Associated with Stone Multiplicity in Calcium Nephrolithiasis Patients.
Mediators Inflamm. 2015;2015:375427. doi: 10.1155/2015/375427. Epub 2015 May 18.
8
A polymorphism of matrix Gla protein gene is associated with kidney stone in the Chinese Han population.
Gene. 2012 Dec 15;511(2):127-30. doi: 10.1016/j.gene.2012.09.112. Epub 2012 Oct 6.
9
A polymorphism of the ORAI1 gene is associated with the risk and recurrence of calcium nephrolithiasis.
J Urol. 2011 May;185(5):1742-6. doi: 10.1016/j.juro.2010.12.094. Epub 2011 Mar 21.
10
Urokinase gene 3'-UTR T/C polymorphism is associated with urolithiasis.
Urology. 2002 Mar;59(3):458-61. doi: 10.1016/s0090-4295(01)01576-x.
Zotero 插件